These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38051359)

  • 1. Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis.
    Ferri V; Vicente E; Quijano Y; Duran H; Diaz E; Fabra I; Malave L; Ruiz P; Costantini G; Pizzuti G; Cubillo A; Rubio MC; Cañamaque LG; Alfonsel JN; Caruso R
    Int J Colorectal Dis; 2023 Dec; 38(1):277. PubMed ID: 38051359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
    Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
    Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
    Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
    JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness and Quality-Adjusted Survival of Watch and Wait After Complete Response to Chemoradiotherapy for Rectal Cancer.
    Miller JA; Wang H; Chang DT; Pollom EL
    J Natl Cancer Inst; 2020 Aug; 112(8):792-801. PubMed ID: 31930400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
    Wang QX; Zhang R; Xiao WW; Zhang S; Wei MB; Li YH; Chang H; Xie WH; Li LR; Ding PR; Chen G; Zeng ZF; Wang WH; Wan XB; Gao YH
    Radiat Oncol; 2021 Jan; 16(1):16. PubMed ID: 33468176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series.
    Asoglu O; Bulut A; Aliyev V; Piozzi GN; Guven K; Bakır B; Goksel S
    World J Surg Oncol; 2022 Nov; 20(1):358. PubMed ID: 36352416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
    Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
    Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Watch-and-Wait policy versus robotic surgery for locally advanced rectal cancer: A cost-effectiveness study (RECCOSTE).
    Rodriguez-Pascual J; Nuñez-Alfonsel J; Ielpo B; Lopez M; Quijano Y; de Vicente E; Cubillo A; Saborido CM
    Surg Oncol; 2022 May; 41():101710. PubMed ID: 35151941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery may not benefit patients with locally advanced rectal cancer who achieved clinical complete response following neoadjuvant chemoradiotherapy.
    Han Z; Li M; Chen J; Ji D; Zhan T; Peng Y; Xue W; Li Y; Cai Y; Sun Y; Wu Q; Du C; Gu J
    Asian J Surg; 2022 Jan; 45(1):97-104. PubMed ID: 33888366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the "watch-and-wait" approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis.
    Zhang X; Ding R; Li J; Wu T; Shen Z; Li S; Zhang Y; Dong C; Shang Z; Zhou H; Li T; Li G; Li Y
    Surg Endosc; 2022 Apr; 36(4):2233-2244. PubMed ID: 34981233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
    Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
    Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.